RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Anomer Bio

Anomer Bio

Anomer Bio: Glycan-targeted small molecule drugs to tackle disease at its first layer of interaction

Website: anomer.bio.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Medical, Product Research.
Based in: London, United Kingdom.
Domain age: 13 months.
On Recent Funding since: Oct 11, 2026.
About Anomer Bio

Anomer Bio is a company based in London, United Kingdom. Recent Funding lists it under Health and bio. It went through IndieBio (IndieBio NY 2025 H2). Investors on record for it include SOSV and SOSV SF & NY (Fka IndieBio). It was founded by Sophie James, Marcos Burger Ramos and Oliver Pearce.

Funding rounds

  1. Website created
  2. IndieBio NY 2025 H2
    IIndieBio · batch
    Source: indiebio.co

Founders and team

Investors

Similar Health and bio companies

Questions and sources

Anomer Bio: questions and answers

Who invested in Anomer Bio?
Investors on record for Anomer Bio: IndieBio, SOSV and SOSV SF & NY (Fka IndieBio).
Who founded Anomer Bio?
Anomer Bio was founded by Sophie James (Co-founder and CEO), Marcos Burger Ramos (Co-founder and CSO) and Oliver Pearce (Scientific co-founder and advisor).
Where is Anomer Bio based?
Anomer Bio is based in London, United Kingdom.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/anomer-bio (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy